Medtronic plc
MDT · NYSE
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Market Cap | $109 | $107 | $121 | $140 |
| - Cash | $2 | $1 | $2 | $4 |
| + Debt | $29 | $25 | $24 | $24 |
| Enterprise Value | $135 | $130 | $143 | $160 |
| Revenue | $34 | $32 | $31 | $32 |
| % Growth | 3.6% | 3.6% | -1.4% | – |
| Gross Profit | $22 | $21 | $21 | $22 |
| % Margin | 65.3% | 65.3% | 65.7% | 68% |
| EBITDA | $9 | $8 | $9 | $9 |
| % Margin | 27.5% | 25.3% | 27.9% | 27.7% |
| Net Income | $5 | $4 | $4 | $5 |
| % Margin | 13.9% | 11.4% | 12% | 15.9% |
| EPS Diluted | 3.61 | 2.76 | 2.82 | 3.73 |
| % Growth | 30.8% | -2.1% | -24.4% | – |
| Operating Cash Flow | $7 | $7 | $6 | $7 |
| Capital Expenditures | -$2 | -$2 | -$1 | -$1 |
| Free Cash Flow | $5 | $5 | $5 | $6 |